Cabazitaxel EVER Pharma 10 mg/ml 10mg/ml Infusion Forenede Arabiske Emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

cabazitaxel ever pharma 10 mg/ml 10mg/ml infusion

pharmalink store germany - 1's [6 ml glass vial x 1] - infusion - 10mg/ml - malignant disease , immumosuppression-cytotoxic drugs

Cabitas 20 mg/mL Concentrate for Solution for IV Infusion Filippinerne - engelsk - FDA (Food And Drug Administration)

cabitas 20 mg/ml concentrate for solution for iv infusion

n/a; importer: accord healthcare limited - philippine branch office; distributor: accord healthcare limited - philippine branch office - cabazitaxel - concentrate for solution for iv infusion - 20 mg/ml

Cabazitaxel EVER Pharma 10 mg/ml Forenede Arabiske Emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

cabazitaxel ever pharma 10 mg/ml

1's [6 ml glass vial x 1] -

Xatiza 60 mg / 1.5 ml Concentrate and solvent for solution for injection Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

xatiza 60 mg / 1.5 ml concentrate and solvent for solution for injection

boston oncology arabia, saudi arabia - cabazitaxel - concentrate and solvent for solution for injection - 40 mg/ml,

Anavalin Concentrate for solution for infusion Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

anavalin concentrate for solution for infusion

ever neuro pharma gmbh, austria - cabazitaxel - concentrate for solution for infusion - 10 mg/ml,

Cabxel 60 mg/1.5 mL Concentrate for Solution for IV Infusion Filippinerne - engelsk - FDA (Food And Drug Administration)

cabxel 60 mg/1.5 ml concentrate for solution for iv infusion

n/a; importer: camber pharmaceuticals, inc.; distributor: camber pharmaceuticals, inc. - cabazitaxel - concentrate for solution for iv infusion - 60 mg/1.5 ml

XTANDI 40 MG Israel - engelsk - Ministry of Health

xtandi 40 mg

astellas pharma international b.v., israel - enzalutamide - capsules soft - enzalutamide 40 mg - enzalutamide - xtandi is indicated for:• the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc).• the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated.• the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

XTANDI 40 MG CAPSULES Israel - engelsk - Ministry of Health

xtandi 40 mg capsules

astellas pharma international b.v., israel - enzalutamide - capsules soft - enzalutamide 40 mg - enzalutamide - xtandi is indicated for:•the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc). •the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. •the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.• the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy

Sporanox New Zealand - engelsk - Medsafe (Medicines Safety Authority)

sporanox

janssen-cilag (new zealand) ltd - itraconazole 10 mg/ml - oral solution - 10 mg/ml - active: itraconazole 10 mg/ml excipient: caramel cherry flavour 654536 cherry flavour 654595 hydrochloric acid hydroxypropyl-beta-cyclodextrin propylene glycol purified water saccharin sodium sodium hydroxide sorbitol - sporanox oral solution is indicated for the: · treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. · prophylaxis of fungal infections in neutropenic patients.

SPORANOX ORAL SOLUTION Israel - engelsk - Ministry of Health

sporanox oral solution

j-c health care ltd - itraconazole - solution - itraconazole 10 mg/ml - itraconazole - itraconazole - sporanox oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. prevention of fungal infection during neutropenia of immunodeficient patients.